Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.

European journal of cancer (Oxford, England : 1990) - 1 Jul 2011

Laugsand Eivor A, Fladvad Torill, Skorpen Frank, Maltoni Marco, Kaasa Stein, Fayers Peter, Klepstad Pål

Abstract excerpt

BACKGROUND: This study investigates whether demographical, disease-related and genetic factors contribute to inter-individual differences in nausea and vomiting among patients receiving opioids for cancer pain. METHODS: Cancer patients receiving opioids were included from 17 centres in 11 European countries. Intensities of nausea and vomiting were reported by 1579 patients on four-point categorical scales. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Analgesics, Opioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Gene Expression Regulation, Neoplastic

Share to Nausea

Share to Neoplasms

Share to Signal Transduction

Share to Vomiting

Source

Identifiers

PMID: 21570824
DOI: 10.1016/j.ejca.2011.04.014

Genes

CHRM3
COMT
ABCB1
ARRB2
CHRM5
CNR1
DRD2
DRD3
HRH1
OPRK1
OPRM1
STAT6
TACR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.PMID 21570824Read ↗

Role of genetic polymorphisms on opioid safety and efficacy in cancer pain: A systematic review and meta-analysis.Semantic proximity Read ↗

A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.Semantic proximity Read ↗

Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.Semantic proximity Read ↗

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients.Semantic proximity Read ↗

A European pharmacogenomic study of the response to opioids in advanced cancer patients identifies germline variants associated with nausea-vomiting side effectSemantic proximity Read ↗

Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study.Semantic proximity Read ↗

Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.Semantic proximity Read ↗

Exploring the multifactorial nature of postoperative nausea and vomiting in women following surgery for breast cancer.Semantic proximity Read ↗

Pharmacogenetics of Chemotherapy-Induced Nausea and VomitingSemantic proximity Read ↗

Genetic variability in postoperative nausea and vomiting: A systematic review.Semantic proximity Read ↗

TMEM132C rs7296262 Single-Nucleotide Polymorphism Is Significantly Associated with Nausea Induced by Opioids Administered for Cancer Pain and Postoperative Pain.Semantic proximity Read ↗

Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.